Compliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial
Przemyslaw KardasThe First Department of Family Medicine, Medical University of LodzBackground: A randomized, controlled trial was conducted in an outpatient setting to examine the effect of beta-blocker dosing frequency on patient compliance, clinical outcome, and health-related quality of life in...
Main Author: | Przemyslaw Kardas |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2007-05-01
|
Series: | Vascular Health and Risk Management |
Online Access: | https://www.dovepress.com/compliance-clinical-outcome-and-quality-of-life-of-patients-with-stabl-peer-reviewed-article-VHRM |
Similar Items
-
COMPARISON BETAXOLOL AND METOPROLOL TARTRATE THERAPIES IN PATIENTS WITH ARTERIAL HYPERTENSION ASSOCIATED WITH STABLE ANGINA
by: A. A. Anderzhanova, et al.
Published: (2016-01-01) -
COMPARISON BETAXOLOL AND METOPROLOL TARTRATE THERAPIES IN PATIENTS WITH ARTERIAL HYPERTENSION ASSOCIATED WITH STABLE ANGINA
by: A. A. Anderzhanova, et al.
Published: (2016-01-01) -
Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable heart failure
by: Inder S Anand, et al.
Published: (2010-06-01) -
Compliance with once-daily versus twice or thrice-daily administration of antibiotic regimens: a meta-analysis of randomized controlled trials.
by: Matthew E Falagas, et al.
Published: (2015-01-01) -
Comparison of once daily versus twice daily olmesartan in patients with chronic kidney disease
by: Sakai Y, et al.
Published: (2013-10-01)